Synapse - Miguel-Angel Perales

Results (942)

Impact of TP53 genomic alterations in large B-cell lymphoma treated with CD19-chimeric antigen receptor T-cell therapy

Journal Article

Shouval, R.; Alarcon Tomas, A.; Fein, J. A.; Flynn, J. R.; Markovits, E.; Mayer, S.; Afuye, A. O.; Alperovich, A.; Anagnostou, T.; Besser, M. J.; more...
Journal of Clinical Oncology (2022)

Fulltext@MSK | Save

Antithymocyte globulin exposure in CD34(+) T-cell–depleted allogeneic hematopoietic cell transplantation

Journal Article

Lakkaraja, M.; Scordo, M.; Mauguen, A.; Cho, C.; Devlin, S.; Ruiz, J. D.; Klein, E.; Avecilla, S. T.; Boulad, F.; Cancio, M. I.; more...
Blood Advances (2022)

Fulltext@MSK | Save

Combining the Disease Risk Index and Hematopoietic Cell Transplant Co-Morbidity Index provides a comprehensive prognostic model for CD34(+)-selected allogeneic transplantation

Journal Article

Cho, C.; Hilden, P.; Avecilla, S. T.; Barker, J. N.; Castro-Malaspina, H.; Giralt, S. A.; Gyurkocza, B.; Jakubowski, A. A.; Maloy, M. A.; O'Reilly, R. J.; more...
Advances in Cell and Gene Therapy (2021)

Fulltext@MSK | Save

Highly selective irreversible ITK inhibitor Cpi-818 reduces acute graft-versus host disease

Meeting Abstract

Lindner, S.; Lee, N.; Armijo, G. K.; Burgos da Silva, Marina; Herrera, P. S.; Nguyen, C. L.; Dwomoh, E. A.; Ghale, R.; Smith, M.; Perales, M. A.; more...
Blood (2021)

Fulltext@MSK | Save

Post-transplant cyclophosphamide is associated with improved clinical outcomes in HLA-mismatched unrelated donor hematopoietic cell transplantation

Meeting Abstract

Jimenez, A. M.; Perales, M. A.; Devlin, S. M.; Lekakis, L. J.; Sauter, C. S.; Pereira, D.; Beitinjaneh, A.; Brown, S.; Wang, T.; Ponce, D. M.; more...
Blood (2021)

Fulltext@MSK | Save

Outcomes of aggressive B cell lymphoma patients with no evidence of measurable disease at the time of CD19 chimeric antigen receptor T cell therapy: The experience from the CAR T Cell Consortium

Meeting Abstract

Wudhikarn, K.; Tomas, A. A.; Brower, J.; Bachanova, V.; Maziarz, R. T.; McGuirk, J. P.; Nastoupil, L.; Porter, D. L.; Riedell, P. A.; Perales, M. A.
Blood (2021)

Fulltext@MSK | Save

Pharmacodynamic analysis of CAR-T cell persistence in patients with hematologic malignancies treated with NKTR-255, an IL-15 receptor agonist that enhances CD8 (+) T-cells: Preliminary results from a phase 1 study

Meeting Abstract

Turtle, C. J.; Budde, E.; Patel, K. K.; Perales, M. A.; Cowan, A. J.; Saeed, H.; Chavez, J. C.; Hirayama, A. V.; Kirchmeier, D. R.; Janakiram, M.; more...
Blood (2021)

Fulltext@MSK | Save

Novel agents may be preferable to chemotherapy for large B-cell lymphoma progressing after CD19-CAR-T: A multicenter observational study

Meeting Abstract

Tomas, A. A.; Fein, J. A.; Fried, S.; Fingrut, W.; Anagnostou, T.; Alperovich, A.; Shah, N.; Fraint, E.; Lin, R. J.; Scordo, M.; more...
Blood (2021)

Fulltext@MSK | Save

Timing and immune status after cellular therapies predict response to COVID-19 vaccines

Meeting Abstract

Tamari, R.; Politikos, I.; Knorr, D.; Vardhana, S.; Young, J.; Marcello, L.; Doddi, S.; Devlin, S. M.; Ramanathan, L.; Pessin, M. S.; more...
Blood (2021)

Fulltext@MSK | Save

The intestinal microbiota correlates with response and toxicity after CAR T cell therapy in patients with B-cell malignancies

Meeting Abstract

Smith, M.; Dai, A.; Ghilardi, G.; Amelsberg, K.; Devlin, S. M.; Pajarillo, R.; Slingerland, J. B.; Beghi, S.; Herrera, P. S.; Giardina, P. A.; more...
Blood (2021)

Fulltext@MSK | Save